Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme
- 1 October 1997
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 4 (10) , 1045-1052
- https://doi.org/10.1038/sj.gt.3300510
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 0 references indexed in Scilit: